<i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis
<i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis have?
<i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis has 10 citations in the OpenAlex counts ScholarIQ stores.
When was <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis published?
<i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis has 2020 year in the ScholarIQ index.
What is the open-access status of <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis?
<i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis has hybrid oa status in the ScholarIQ index.
What is the DOI of <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis?
The DOI for <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis is on the source record.
What is the PMID of <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis?
The PMID for <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis is on the source record.
What is the OpenAlex record for <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis?
The OpenAlex for <i>In Vitro</i> and <i>In Vivo</i> Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis is on the source record.